AXIN1 and obstructive sleep apnea syndrome: miR-3574 upregulation ameliorated IH-induced cardiomyocyte injury through regulating cell viability and apoptosis via Axin1, indicating that miR-3574 and Axin1 can serve as a potential novel and effective therapeutic strategy for OSA-related cardiovascular diseases.